Unity Biotechnology, Inc.
UBX
$0.977
-$0.0067-0.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.11% | -94.47% | 56.17% | 65.84% | -9.68% |
| Total Depreciation and Amortization | -21.59% | -12.12% | -29.87% | -29.62% | -31.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 219.14% | 164.39% | -92.53% | -115.81% | 86.09% |
| Change in Net Operating Assets | -89.24% | 176.69% | 79.94% | 203.84% | 135.29% |
| Cash from Operations | -22.65% | 22.05% | 27.00% | 58.64% | 54.20% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -100.00% | 600.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 193.99% | -69.48% | -54.41% | -52.61% | -133.88% |
| Cash from Investing | 194.24% | -69.71% | -54.33% | -52.61% | -133.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -99.79% | -- | -88.83% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -99.79% | 100.00% | 102.59% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.39% | -111.05% | 111.69% | 104.00% | -220.88% |